Efficacy of FOLFIRI as a second -line in extrapulmonary poorly differentiated neuroendocrine carcinoma

被引：0
|
作者：
Fabregat-Franco, Carles [1 ]
Munoz, M. Nieva [2 ]
Martin, F. Perez [3 ]
Ruffinelli, J. [2 ]
Vivas, C. Santos [4 ,5 ]
Sanchez, C. [6 ]
Salazar, R. [7 ,8 ]
Teule, A. [9 ]
机构：
[1] Inst Catalan Oncol, Lhospitalet De Llobregat, Spain
[2] Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[3] IDIBELL, Clin Res Unit, Inst Catala Oncol ICO Lhospitalet, Lhospitalet De Llobregat, Spain
[4] Inst Catala Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain
[5] Inst Catala Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
[6] Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[7] Inst Catala Oncol, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[8] Inst Catala Oncol, IDIBELL, Lhospitalet De Llobregat, Spain
[9] Inst Catala Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz155.309
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P 310
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Comparative Efficacy of 2nd-Line Chemotherapy Regimens in Extrapulmonary Poorly-Differentiated Neuroendocrine Carcinoma (PD NEC): The Mayo Clinic Experience
    McGarrah, P.
    Leventakos, K.
    Hobday, T.
    Molina, J.
    Finnes, H.
    Westin, G.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2019, 108 : 155 - 155
  • [12] Carboplatin and etoposide chemotherapy in extrapulmonary poorly differentiated neuroendocrine carcinomas
    Galdy, S.
    Aurilio, G.
    Radice, D.
    Spada, F.
    Cella, C. A.
    Frezza, A. M.
    Nole, F.
    Fazio, N.
    ANNALS OF ONCOLOGY, 2015, 26 : 138 - 138
  • [13] Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma
    Kumar, Sakthi
    Talabi, Toluwalase
    Mahmoudieh, Mahta
    Pennington, Daniel
    Saboda, Kathylynn
    Arshad, Junaid
    Scott, Aaron James
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [14] Poorly differentiated orbital neuroendocrine carcinoma
    Zhang, Yi Stephanie
    Jiro, Marycon
    Pekmezci, Melike
    Winn, Bryan
    BMJ CASE REPORTS, 2023, 16 (08)
  • [15] Poorly Differentiated Neuroendocrine Carcinoma of the Eyelid
    Cho, Kyuyeon
    Kim, Jeong Hee
    Lee, Dong-Cheol
    Suh, Yeon Lim
    Woo, Kyung In
    Kim, Yoon-Duck
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2018, 59 (09): : 861 - 866
  • [16] The Management of Extrapulmonary Poorly Differentiated (High-Grade) Neuroendocrine Carcinomas
    Smith, James
    Reidy-Lagunes, Diane
    SEMINARS IN ONCOLOGY, 2013, 40 (01) : 100 - 108
  • [17] Poorly differentiated neuroendocrine carcinoma of the seminal vesicle
    Yasunaga, Yutaka
    Ueda, Takafumi
    Kodama, Yoshinori
    Oka, Toshitsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (04) : 370 - 372
  • [18] A poorly differentiated thyroid carcinoma with neuroendocrine traits
    Boronat, M
    Isla, C
    Nóvoa, FJ
    Cabrera, JJ
    THYROID, 2004, 14 (02) : 163 - 164
  • [19] Treatment of Poorly Differentiated Neuroendocrine Carcinoma of the Pancreas
    Gupta, Anumeha
    Duque, Marvin
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (04): : 381 - 383
  • [20] EXTRAPULMONARY POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMAS (PDNEC) TREATED WITH CISPLATIN PLUS IRINOTECAN
    de Celis Ferrari, Anezka Rubin
    Braghiroli, Maria Ignez
    Bariani, Giovanni Mendonca
    Munhoz, Rodrigo Ranella
    Pfiffer, Tulio Eduardo
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    ANNALS OF ONCOLOGY, 2011, 22 : v80 - v80
12345